Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical trials in predementia stages of Alzheimer disease.

The Medical clinics of North America - 1 May 2013

Pillai Jagan A, Cummings Jeffrey L

Abstract excerpt

Effective treatments of Alzheimer disease (AD) dementia are an urgent necessity. There is a growing consensus that effective disease-modifying treatment before the onset of clinical dementia and slowing the progression of mild symptoms are needed after recent setbacks in AD therapeutics. The identification of at-risk and preclinical AD populations is becoming important for targeting primary and secondary...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asymptomatic Diseases
Share to Clinical Trials as Topic
Share to Cognition

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cognitive Dysfunction

Share to Drugs, Investigational

Share to Patient Selection

Share to Primary Prevention

Share to Randomized Controlled Trials as Topic

Source

Identifiers

PMID: 23642580
DOI: 10.1016/j.mcna.2013.01.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical trials in predementia stages of Alzheimer disease.PMID 23642580Read ↗

Preclinical Alzheimer disease-the challenges ahead.Semantic proximity Read ↗

Diagnosis and treatment of Alzheimer's disease.Semantic proximity Read ↗

Preventing Alzheimer's disease.Semantic proximity Read ↗

New approaches to diagnose and treat Alzheimer's disease: a glimpse of the future.Semantic proximity Read ↗

Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's diseaseSemantic proximity Read ↗

Use of preclinical Alzheimer’s disease trajectories for clinical trial designSemantic proximity Read ↗

The Alzheimer’s disease drug development landscapeSemantic proximity Read ↗

Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging InitiativeSemantic proximity Read ↗

Future scenarios for the prevention and delay of Alzheimer disease onset in high-risk groups. An ethical perspective.Semantic proximity Read ↗

Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress.Semantic proximity Read ↗

FDA-Approved Passive Immunization Treatments Against Aβ in Alzheimer’s Disease: Where Are We Now?Semantic proximity Read ↗

Endpoints in preclinical Alzheimer's disease trials.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.